Early clinical research outcomes of the Total Body PET Posted on June 18, 2025June 19, 2025 by Sarah Cole
First dementia treatment drug approved for Australia, supported by NIF capacity Posted on June 16, 2025June 16, 2025 by Sarah Cole
Sharing the Australian National Total Body PET Facility: a win–win for researchers and clinicians Posted on June 3, 2025June 3, 2025 by Sarah Cole
Network models brain changes in motor neurone disease to develop imaging tools for clinicians Posted on May 28, 2025May 29, 2025 by Sarah Cole
WHO adopts resolution to improve access to medical imaging globally Posted on May 26, 2025June 2, 2025 by Sarah Cole
New molecular-imaging network launched to benefit cancer, dementia imaging and new radiopharmaceuticals Posted on May 26, 2025 by Sarah Cole
Advance Queensland: AI-powered software to optimise brain stimulation therapy for major depression Posted on February 18, 2025April 7, 2025 by aburton
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing Posted on February 3, 2025February 6, 2025 by aburton
